161 related articles for article (PubMed ID: 37801893)
1. Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD.
Dai S; Chen Y; Fan X; Han J; Zhong L; Zhang Y; Liu Q; Lin J; Huang W; Su L; Huang Z; Ye B
Phytomedicine; 2023 Dec; 121():155105. PubMed ID: 37801893
[TBL] [Abstract][Full Text] [Related]
2. Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage.
Ye B; Shi X; Xu J; Dai S; Xu J; Fan X; Han B; Han J
Transl Res; 2022 Oct; 248():36-50. PubMed ID: 35545198
[TBL] [Abstract][Full Text] [Related]
3. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
[TBL] [Abstract][Full Text] [Related]
4. Gasdermin D mediates endoplasmic reticulum stress via FAM134B to regulate cardiomyocyte autophagy and apoptosis in doxorubicin-induced cardiotoxicity.
Qu Y; Gao R; Wei X; Sun X; Yang K; Shi H; Gao Y; Hu S; Wang Y; Yang J; Sun A; Zhang F; Ge J
Cell Death Dis; 2022 Oct; 13(10):901. PubMed ID: 36289195
[TBL] [Abstract][Full Text] [Related]
5. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
[TBL] [Abstract][Full Text] [Related]
6. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV Alleviates Doxorubicin-Induced Cardiotoxicity by Inhibiting Cardiomyocyte Pyroptosis through the SIRT1/NLRP3 Pathway.
Tian W; Zhang P; Yang L; Song P; Zhao J; Wang H; Zhao Y; Cao L
Am J Chin Med; 2024; 52(2):453-469. PubMed ID: 38490806
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of NR4A1 alleviates doxorubicin-induced cardiotoxicity through inhibiting the activation of the NLRP3 inflammasome.
Hu H; Zhong Z; Meng L; Chen J; Yu Z; Lu K
Biochem Biophys Res Commun; 2024 Mar; 700():149582. PubMed ID: 38306930
[TBL] [Abstract][Full Text] [Related]
9. Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3.
Zhang J; Li W; Xue S; Gao P; Wang H; Chen H; Hong Y; Sun Q; Lu L; Wang Y; Wang Q
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117134. PubMed ID: 37714227
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic study of Huangqi Guizhi Wuwu decoction amelioration of doxorubicin-induced cardiotoxicity by reducing oxidative stress and inhibiting cellular pyroptosis.
Chen Y; Xu M; Liu XM; Wang JX; Sun MF; Song JX; Guan P; Ji ES; Wang N
Biomed Pharmacother; 2024 Jun; 175():116653. PubMed ID: 38688172
[TBL] [Abstract][Full Text] [Related]
11. PLCE1 enhances mitochondrial dysfunction to promote GSDME-mediated pyroptosis in doxorubicin-induced cardiotoxicity.
Tuersuntuoheti M; Peng F; Li J; Zhou L; Gao H; Gong H
Biochem Pharmacol; 2024 May; 223():116142. PubMed ID: 38499110
[TBL] [Abstract][Full Text] [Related]
12. Emodin ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through the remodeling of gut microbiota composition.
Hu S; Zhou J; Hao J; Zhong Z; Wu H; Zhang P; Yang J; Guo H; Chi J
Am J Physiol Cell Physiol; 2024 Jan; 326(1):C161-C176. PubMed ID: 38009195
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
[TBL] [Abstract][Full Text] [Related]
14. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.
Hwang S; Kim SH; Yoo KH; Chung MH; Lee JW; Son KH
BMC Mol Cell Biol; 2022 Dec; 23(1):55. PubMed ID: 36517746
[TBL] [Abstract][Full Text] [Related]
15. Bnip3 mediates doxorubicin-induced cardiomyocyte pyroptosis via caspase-3/GSDME.
Zheng X; Zhong T; Ma Y; Wan X; Qin A; Yao B; Zou H; Song Y; Yin D
Life Sci; 2020 Feb; 242():117186. PubMed ID: 31862454
[TBL] [Abstract][Full Text] [Related]
16. Aucubin alleviates doxorubicin-induced cardiotoxicity through crosstalk between NRF2 and HIPK2 mediating autophagy and apoptosis.
Li W; Cao J; Zhang Y; Ling G; Tan N; Wei Y; Zhang Y; Wang X; Qian W; Jiang J; Zhang J; Wang W; Wang Y
Phytomedicine; 2024 May; 127():155473. PubMed ID: 38422972
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV Inhibits NLRP3 Inflammasome-Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction.
Chen X; Tian C; Zhang Z; Qin Y; Meng R; Dai X; Zhong Y; Wei X; Zhang J; Shen C
Front Biosci (Landmark Ed); 2023 Mar; 28(3):45. PubMed ID: 37005753
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stromal cell-derived exosomes improve oxidative stress and pyroptosis in doxorubicin-induced myocardial injury in vitro by regulating the transcription of GSDMD through the PI3K-AKT-Foxo1 pathway.
Zeng H; Yang Y; Tou F; Zhan Y; Liu S; Zou P; Chen Y; Shao L
Immun Inflamm Dis; 2023 Mar; 11(3):e810. PubMed ID: 36988259
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting mir-34a-5p regulates doxorubicin-induced autophagy disorder and alleviates myocardial pyroptosis by targeting Sirt3-AMPK pathway.
Zhong Z; Gao Y; Zhou J; Wang F; Zhang P; Hu S; Wu H; Lou H; Chi J; Lin H; Guo H
Biomed Pharmacother; 2023 Dec; 168():115654. PubMed ID: 37806095
[TBL] [Abstract][Full Text] [Related]
20. Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation.
Zhang L; Fan C; Jiao HC; Zhang Q; Jiang YH; Cui J; Liu Y; Jiang YH; Zhang J; Yang MQ; Li Y; Xue YT
Oxid Med Cell Longev; 2022; 2022():1733834. PubMed ID: 35035656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
